Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 13, 2017
hace1 Influences zebrafish cardiac development via ROS-dependent mechanismsBabak Razaghi, Shelby L Steele, Sergey V Prykhozhij, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 6, 2024
tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypesKim Kobar, Lissandra Tuzi, Jennifer A Fiene, et al.Science Translational Medicine|December 16, 2014
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenaseYan Liu, Aarti Asnani, Lin Zou, et al.Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.Blood|April 9, 2017
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trialJeffrey W Taub, Jason N Berman, Johann K Hitzler, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.Blood|July 28, 2021
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trialJohann Hitzler, Todd Alonzo, Robert Gerbing, et al.Journal of Medical Genetics|September 6, 2015
Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)Santhosh Dhanraj, Sethu Madhava Rao Gunja, Adam P Deveau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing SarcomaSarah Wang, Elizabeth E Hwang, Rajarshi Guha, et al.Pageof 10